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 POSTOPERATIVE MONITORING OF LOWER LIMB FREE FLAPS
WITH THE COOK–SWARTZ IMPLANTABLE DOPPLER PROBE:
A CLINICAL TRIAL
WARREN M. ROZEN, M.B.B.S., B.Med.Sc., P.G.Dip.Surg.Anat., Ph.D.,1 MORTEZA ENAJAT, B.A.,2
IAIN S. WHITAKER, B.A. (Hons), M.A. (Cantab), M.B.B.Chir., M.R.C.S.,3 ULRICA LINDKVIST, B.Physio.,2
THORIR AUDOLFSSON, M.D.,2 and RAFAEL ACOSTA, M.D., EBOPRAS2*
Background: Free ﬂaps to the lower limb have inherently high venous pressures, potentially impairing ﬂap viability, which may lead to limb
amputation if ﬂap failure ensues. Adequate monitoring of ﬂap perfusion is thus essential, with timely detection of ﬂap compromise able to
potentiate ﬂap salvage. While clinical monitoring has been popularized, recent use of the implantable Doppler probe has been used with
success in other free ﬂap settings. Methods: A comparative study of 40 consecutive patients undergoing microvascular free ﬂap recon-
struction of lower limb defects was undertaken, with postoperative monitoring achieved with either clinical monitoring alone or the use of
the Cook-Swartz implantable Doppler probe. Results: The use of the implantable Doppler probe was associated with salvage of 2/2 com-
promised ﬂaps compared to salvage of 2/5 compromised ﬂaps in the group undergoing clinical monitoring alone (salvage rate 100% vs.
40%, P 5 0.28). While not statistically signiﬁcant, this was a strong trend toward an improved ﬂap salvage rate with the use of the implant-
able Doppler probe. There were no false positives or negatives in either group. One ﬂap loss in the clinically monitored group resulted in
limb amputation (the only amputation in the cohort). Conclusion: A trend toward early detection and salvage of ﬂaps with anastomotic
insufﬁciency was seen with the use of the Cook–Swartz implantable Doppler probe. These ﬁndings suggest a possible beneﬁt of this tech-
nique as a stand-alone or adjunctive tool in the clinical monitoring of free ﬂaps, with further investigation warranted into the broader appli-
cation of these devices. VC 2009 Wiley-Liss, Inc. Microsurgery 30:354–360, 2010.
Free ﬂap coverage to lower limb defects are required in
a range of clinical settings. These ﬂaps are unique in that
there are inherently high venous pressures in the lower
limb due to gravitational effects, potentially incompetent
veins and relative dependant edema.1,2 Additionally, both
dressings and mobilization can further increase these
pressures, potentially impairing ﬂap viability, which in
the lower limb setting may lead to limb amputation if
ﬂap failure ensues. Adequate monitoring of ﬂap perfusion
is thus essential to avoid these complications, with timely
detection of ﬂap compromise able to potentiate ﬂap
salvage.
To date, clinical monitoring has formed the basis for
monitoring lower limb free ﬂaps across institutions and
throughout the literature, with signs such as skin color,
capillary reﬁll, bleeding, and temperature the key features
assessed. The Doppler probe has also been used as an
adjunct to clinical monitoring,3,4 with Doppler shown to
be noninvasive, inexpensive, easy to perform, and repro-
ducible.5,6 However, limitations to these techniques
include a degree of inaccuracy due to the subtle nature of
the signs of vascular compromise, the inability to perform
continuous monitoring, and the need for ﬂap exposure to
perform the tests. This is compounded in the setting of
early mobilization, which increases venous pressures and
may threaten the venous drainage of ﬂaps. However
guidelines for mobilizing these ﬂaps and the means for
ﬂap monitoring in this setting have not been described.
The implantable Doppler probe has been described as
an additional tool for ﬂap monitoring, shown to be highly
beneﬁcial in a range of clinical settings.7–11 An internal
Doppler cuff is attached to an external monitor, which
allows continuous monitoring of pedicle ﬂow. In the set-
tings of buried ﬂaps and in breast reconstruction, these
probes have shown distinctive beneﬁts, but the unique
scenario of lower limb ﬂaps warrants particular attention.
Our experiences with implantable probes for lower limb
free ﬂaps have demonstrated unique beneﬁts from the
time of ﬂap in-insetting, to the immediate postoperative
period, and particularly during limb elevation, the appli-
cation of pressure dressings, mobilization, and during
physiotherapy. We thus undertook a study to comparing
the implantable Doppler probe to clinical monitoring
alone in the monitoring of free ﬂaps to the lower extrem-
ities, the ﬁrst such study to compare clinical outcomes of
this adjunctive monitoring tool in this setting.
METHODS
A prospectively entered, retrospectively reviewed
cohort study was undertaken comprising 40 consecutive
patients undergoing microvascular free ﬂap reconstruction
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of a lower limb defect in the period from September
2004 to September 2008. Of these, the ﬁrst 20 patients
were monitored postoperatively with clinical assessment
only, while the subsequent 20 patients were monitored
with the Cook–Swartz implantable Doppler probe (Cook
Medical1, Cook Ireland Ltd, Limerick, Ireland). All
patients were recruited through a single surgeon (RA),
with patient demographics (see Table 1) and ﬂap details
(see Table 2) all recorded. Complications, reoperations,
and clinical outcome measures were compared between
groups.
In the ‘‘clinical assessment only’’ group, postoperative
ﬂap perfusion was monitored through a range of clinical
bedside tests, including the assessment of the color, tem-
perature, tactility, capillary reﬁll, bleeding, and appear-
ance of the ﬂap. Topical temperature monitors and the
hand-held Doppler probe were used adjunctively.
The ‘implantable Doppler probe’ group of ﬂaps was
monitored with the Cook–Swartz implantable Doppler
probe alone (see Fig. 1). The Cook–Swartz venous Dopp-
ler system comprises an implantable 20 MHz ultrasonic
probe and a battery operated portable monitor (see Fig.
2). As per manufacturer and literature speciﬁcations, the
probe is always used on the venous pedicle (as arterial
compromise causes venous changes within minutes), with
the probes attached distal to the venous anastomosis in
all cases. Microclips are used to secure the silicone cuff
around the vessel adventitia, rather than sutures or glue
(see Fig. 3). The tension of the silicone cuff is important,
as a tight cuff may cause venous outﬂow obstruction,
while a loose cuff may be prone to false-positive or
false-negative results. The use of microclips in our expe-
rience minimizes these problems. Multiple venous anasto-
moses can be monitored simultaneously with a single
Cook–Swartz system, by the simple connection of each
wire attachment to each of the two channels on the right
of the monitor (see Fig. 2) and pressing an alternating
switch on the monitor. The probes were turned on imme-
diately intraoperatively, both to ensure proper application
of the probe and to check anastomotic patency during
ﬂap insetting. Any problems detected intraoperatively can
then be re-explored immediately. Continuous monitoring
proceeded into the recovery room.
Monitoring was performed for the ﬁrst 7 days postop-
eratively on the ward during inpatient stay, and continued
for 4 weeks postoperatively. Audible Doppler abnormal-
ities were assessed by the nursing and medical teams, as
well as by the patient themselves. Loss of signal and sig-
niﬁcant changes in the signal were the primary alerts for
further investigation or intervention. In such cases of
abnormal Doppler signal, clinical assessment was also
performed adjunctively. Probes were removed in the out-
patient department after 4 weeks by medical staff by gen-
tle traction on the external component of the wire. Gentle
traction causes release of the wire attachment from the
cuff, without any pedicle damage in our experience of
over 200 cases of using the system in multiple body
regions. A hand-held Doppler probe can be used to con-
ﬁrm pedicle ﬂow after removal of the implanted system.
The standard frequency of ﬂap monitoring in all cases
(both groups) comprised half-hourly monitoring for the
ﬁrst postoperative day, hourly for the second day, 2-
hourly for the third day, and 4-hourly thereafter until
planned discharge on day 7. Postoperatively, all lower ex-
tremity ﬂaps were elevated to at least 10 cm above heart
level for the ﬁrst postoperative week, and further elevated
in cases of suspected venous congestion. Compression
bandages were applied cautiously after 4 postoperative
days and increased during mobilization at the end of the
ﬁrst postoperative week. Postdischarge monitoring with
the probe was performed throughout the early physiother-
apy and rehabilitation process. Changes in Doppler signal
were recorded and patients reviewed in such instances for
the degree of bandage compression and the need for limb
elevation. In all cases (both groups), any positive moni-
toring ﬁnding suggestive of pedicle compromise precipi-
tated an immediate return to theater, with no delays in
theater experienced in either group.
Table 1. Patient Demographics, Comparing the Cook–Swartz
Implantable Doppler Probe and Clinical Assessment Groups
Patient demographics
Cook-Swartz
implantable
Doppler
Clinical
assessment
P
value
Sex (% male) 70 60 0.74
Mean age (years) 45.6, range:
15–73
43.3, range:
1–80
0.70a
Smoking (%) 15 30 0.45
Corticosteroid use (%) 0 15 0.23
Hypertension (%) 15 0 0.23
Diabetes Mellitus (%) 5 0 1
Mean ischaemia
time (minutes) (SD)
80.10 (22.17) 83.35 (26.06) 0.67a
SD, standard deviation.
P values are calculated with the two-tailed Fisher’s exact test.
aP values are calculated with a two tailed Student’s t-test.
Table 2. Presentation of Patients, Comparing the Cook–Swartz
Implantable Doppler Probe and Clinical Assessment Groups
Presenting
problem (n)
Cook-Swartz
implantable
Doppler probe
Clinical
assessment P value
Open fracture 10 10 1.00
Wound Infection 7 6 1.00
Stump coverage
postamputation 1 2 1.00
Traumatic degloving
injury 2 1 1.00
Burn 0 1 1.00
P values calculated with the two-tailed Fisher’s exact test.
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Outcomes assessed for each group included complica-
tions, take-backs to theater, false positives and negatives,
and the rates of salvage of these take-backs. Student’s t-
test was used to compare the means of continuous out-
come variables in the independent groups, calculated at
95% conﬁdence intervals with two-tailed P values given.
The testing of statistical signiﬁcance for nominal data
was done by means of a two-tailed Fisher’s exact test.
Statistical signiﬁcance was considered at P < 0.05.
Statistical analysis was done using Statistical Package for
the Social Sciences (SPSS) for Windows (version 16.0,
SPSS Incorporated, Chicago, IL).
RESULTS
The study comprised 40 consecutive patients, in
which 20 patients were monitored with the Cook–Swartz
implantable Doppler probe and 20 were monitored with
clinical monitoring alone. There were no statistical differ-
ences between the groups in any demographic factors,
including sex, age, smoking habit, comorbidities or pre-
senting complaint/indication for reconstruction (see
Tables 1 and 2). Similarly, they were highly comparable
for ﬂap type, donor and recipient vessels used and ﬂap is-
chemia time (see Tables 1 and 3). All reconstructed
defects were located below the knee, with the ﬂap most
frequently used being the latissimus dorsi musculocutane-
ous ﬂap, and the vessels most frequently used as recipient
vessels being the posterior tibial vessels.
While a range of complications were encountered,
these were statistically similar between groups (see Table
4). The overall success rate was 37 of 40 ﬂaps (93%),
with no signiﬁcant differences in overall ﬂap survival
between groups. Comparable outcomes included rates of
take-back (10% vs. 25%, P 5 0.41), partial ﬂap loss (no
cases in either group) and complete ﬂap loss (0% vs.
15%, P 5 0.23). Monitoring ﬁndings suggestive of anas-
tomotic insufﬁciency occurred in two cases in the group
with Cook-Swartz probe (10%) and in ﬁve cases in the
group without the Cook-Swartz probe (25%) (P 5 0.41).
Figure 1. Postoperative photograph after lower limb free ﬂap cover-
age, demonstrating the Cook–Swartz implantable Doppler probe in
situ, with the ﬂap able to be monitored at the end of the bed, with-
out the need to remove overlying dressings. [Color ﬁgure can be
viewed in the online issue, which is available at www.interscience.
wiley.com.]
Figure 2. The Cook–Swartz implantable venous Doppler system,
comprising the implantable 20 MHz ultrasonic probe, wire connec-
tions, and battery operated portable monitor. [Color ﬁgure can be
viewed in the online issue, which is available at www.interscience.
wiley.com.]
Figure 3. Intraoperative photograph, demonstrating application of
the Doppler probe silicone cuff (arrow) distal to the venous anasto-
mosis, with microclips used to secure the cuff around the vessel
adventitia. [Color ﬁgure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
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Re-explorations were carried out in all such cases of
anastomotic insufﬁciency, and conﬁrmed the presence of
vessel thrombosis (venous thrombosis in all cases, and
one case of both arterial and venous thrombosis). There
were no false positives or false negatives in either group.
Of the take-backs to theater, there was a substantially
higher percentage of compromised ﬂaps able to be sal-
vaged with the use of the Cook–Swartz implantable
Doppler probe. In the Cook–Swartz probe group, none of
the anastomotic insufﬁciencies resulted in ﬂap failure
(two of two ﬂaps salvaged), compared with the clinical
group in which three of the ﬁve anastomotic insufﬁcien-
cies resulted in ﬂap failure (two of ﬁve ﬂaps salvaged),
equating to an overall ﬂap salvage rate of 100% vs. 40%,
P 5 0.28. The improved ﬂap salvage reﬂects an earlier
detection of ﬂap compromise, return to theater, and
improved ability to reverse ischemia by returning pedicle
ﬂow with the use of the Cook–Swartz implantable Dopp-
ler probe. This earlier time course to detection was also
evident when analyzing the time of detection of ﬂap
compromise within the Cook–Swartz probe group, with
the detection of anastomotic insufﬁciency occurring with
the implantable Doppler probe up to several hours before
clinical signs were evident. Of the two cases, both anas-
tomotic thromboses were detected by the Cook–Swartz
implantable Doppler probe and reversed without any clin-
ical signs ever becoming evident, and two displayed clin-
ical signs only by the time the ﬂaps were returned to the-
ater 3–4 hours later. In addition to these factors for early
intervention, the time from operation that ﬂap compro-
mise was detected was uniformly earlier in the Cook–
Swartz probe group than the clinical group: several days
after surgery in the clinical assessment group (mean 2.0
Table 4. Operative Outcomes and Complications, Comparing the Cook–Swartz Implantable Doppler Probe and Clinical Assessment Groups
Cook–Swartz
implantable
Doppler probe
Clinical
assessment P value
Raw data (n/%)
True positives 2/20 5 10% 5/20 5 25% N/A
False positives 0/20 5 0% 0/20 5 0% N/A
True negatives 18/20 5 90% 15/20 5 75% N/A
False negatives 0/20 5 0% 0/20 5 0% N/A
Outcomes (n/%)
Overall survival rate 20/20 5 100% 17/20 5 85% 0.23
Flap salvage rate (salvaged ﬂaps/compromised ﬂaps) 2/2 5 100% 2/5 5 40% 0.28
False-positive rate (false positives/uncompromised ﬂaps) 0/18 5 0% 0/15 5 0% 1.00
False-negative rate (false negatives/compromised ﬂaps) 0/2 5 0% 0/5 5 0% 1.00
Total re-explorations (n/%) 2 (10%) 5 (25%) 0.41
Complications (n/%) 4 (20%) 7 (35%) 0.48
Wound dehiscence 0 1 (5%) 1.00
Hematoma 0 0 1.00
Infection 2 (10%) 3 (15%) 1.00
Seroma 0 0 1.00
Anastomotic insufﬁciency 2 (10%) 5 (25%) 0.41
Partial ﬂap loss/necrosis 0 0 1.00
Total ﬂap loss 0 (0%) 3 (15%) 0.23
Amputation of limb 0 1 (5%) 1.00
P values calculated with Fisher’s exact test.
Table 3. Flap Type and Anastomotic Details, Between the Cook–
Swartz Implantable Doppler Probe and Clinical Assessment Groups
Cook–Swartz
implantable
Doppler probe
Clinical
assessment
P
value
Flap type (n/%)
Anterolateral thigh (ALT) 2 (10) 4 (20) 0.66
Parascapular 1 (5) 1 (5) 1.00
Latissimus dorsi 12 (60) 10 (50) 0.75
Gracillis 0 1 (5) 1.00
Serratus 0 1 (5) 1.00
Lateral arm 4 (20) 3 (15) 1.00
Radial 1 (5) 0 1.00
Recipient artery (n/%)
Posterior tibial 13 (65) 10 (50) 0.52
Anterior tibial 3 (15) 8 (40) 0.16
Dorsalis pedis 1 (5) 0 1.00
Peroneal 1 (5) 0 1.00
Poplitial 0 1.00
Superﬁcial femoral 1 (5) 1 (5) 1.00
Profunda femoris 0 1 (5) 1.00
Recipient vein (n/%)
Posterior tibial 12 (60) 10 (50) 0.75
Anterior tibial 4 (20) 8 (40) 0.30
Dorsalis pedis 1 (5) 0 1.00
Peroneal 1 (5) 0 1.00
Poplitial 1 (5) 0 1.00
Superﬁcial femoral 1 (5) 1 (5) 1.00
Profunda femoris 0 1 (5) 1.00
P values are calculated with the two-tailed Fisher’s exact test.
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days), and minutes to hours postoperatively in the Cook–
Swartz probe group (mean 0.5 days). These three factors
all point to an earlier time course to the detection of
anastomotic insufﬁciency with the Cook–Swartz probe
over clinical monitoring alone. Of further note, is that
one of the ﬂap failures in the clinically monitored group
resulted in amputation of the limb (the only amputation
in the cohort). There were no limb amputations in the
implantable Doppler probe group.
DISCUSSION
Free microvascular tissue transplantation to the lower
limb is associated with higher rates of thrombotic compli-
cations when compared with other body regions.12–14 In
addition to the nature of the injuries requiring reconstruc-
tion (contaminated, infective, traumatized tissues), the
inherently high venous pressures in the lower limb and
the use of compression dressings and mobilization can
further increase these pressures.1,2 The potential impair-
ment to ﬂap viability can thus result in partial or com-
plete ﬂap loss.15,16 Flap loss in this setting can necessitate
amputation of the limb, with amputation rates as high as
18% reported.17 While the success of elective free ﬂaps
in other body regions frequently reaches 98%, such as in
autologous breast reconstruction,18 failure rates as high as
20% have been reported for free ﬂaps to the lower
extremity.19,20 The failure rates in the current study are
thus highly comparable with the literature, with an over-
all ﬂap survival of 93%.
By monitoring the vascular pedicle of these free ﬂaps,
occlusive events (such as arterial or venous thrombosis,
external compression, or kinking of the pedicle) can be
detected at an early stage and rapid return to theater
potentiated. Occlusive events can risk the success of a
free ﬂap, and there is good evidence that the length of
time that a ﬂap remains compromised dictates the ulti-
mate survival of that ﬂap.21–25 Although it is not possible
in this clinical study to identify the exact time that pedi-
cle occlusion began in any single case, there is ample
evidence in these studies to show that early identiﬁcation
of impaired ﬂap viability can potentiate return to theater
and an improved rate of ﬂap salvage.21–25 Effective mon-
itoring of a ﬂap will further improve this, causing an ear-
lier detection of pedicle compromise and resulting in an
improved ﬂap salvage rate. In the current study, the
improved ﬂap salvage rate seen in the Cook–Swartz
implantable Doppler probe group thus reﬂects an earlier
detection of ﬂap compromise, earlier return to theater and
improved ability to reverse ischemia by returning pedicle
ﬂow.
Clinical monitoring has formed the basis of such
monitoring techniques in the past, and is still largely the
gold standard even today. Temperature, skin color, capil-
lary reﬁll, active bleeding, tissue turgor, and the use of
the handheld Doppler probe are all useful for monitoring
ﬂaps.3,4 These techniques are simple to use, inexpensive,
non-invasive and reproducible. However these techniques
require interpretation by experienced staff, and require
the same staff member to repeat the examination in order
to avoid interobserver variability. Overnight particularly,
subjective interpretation and varying levels of experience
of medical and nursing personnel can contribute to inac-
curacies in monitoring. The subtle nature of these signs
is certainly a factor in late presentations, and timely
detection even by experienced staff is often missed.
In addition to observer-based inaccuracies with clini-
cal assessment, there are inherent problems with clinical
assessment. Interpretation of skin color is subjective, and
is inﬂuenced by pigmentation and lighting conditions.26
Differences in the skin color between donor and recipient
sites can also confound. Furthermore, the monitoring of
capillary reﬁll can be difﬁcult with darker skin. Surface
skin temperature can be inﬂuenced by environmental fac-
tors, core temperature, and dressings, with temperature
often considered an unreliable indicator of ﬂap perfu-
sion.27 If ﬂaps lose their sensory innervation, central ther-
moregulation to the ﬂap is lost, further contributing to
dissimilarities between ﬂap temperature and surrounding
tissues.28 Clinical assessment is performed intermittently,
often used 0.5–1 hourly for the ﬁrst 24–48 hours and
reducing thereafter.
The Cook-Swartz implantable probe provides an al-
ternative to clinical assessment. In theory, the implant-
able Doppler detects impairment to pedicle ﬂow, and
may detect ﬂap compromise before clinical ischemia
becomes evident. The Doppler signal is a continuous
monitor, and can be assessed continuously or intermit-
tently, without any need for waking the patient or any
contact with the patient. While other studies have dem-
onstrated the value of the Cook–Swartz Doppler probe
in the salvage of failing ﬂaps, the current study has
demonstrated this effect in the unique setting of lower
limb free ﬂaps.7–11 As discussed, lower limb ﬂaps com-
prise a distinctive group in that these are often emer-
gency cases, in the presence of trauma, vascular injury
or infection, and may be associated with peripheral vas-
cular disease. In addition, the physiology of these ﬂaps
include inherently high venous pressures in the lower
limb due to gravitational effects, potentially incompetent
veins and relative dependant edema.1,2 Both dressings
and mobilization (dependency) can further increase these
pressures, potentially impairing ﬂap viability, which in
the lower limb setting may lead to limb amputation if
ﬂap failure ensues.
In our series, the probe was applied to the venous
pedicle, with previous studies showing that the venous
signal is lost within minutes of loss of either venous or
358 Rozen et al.
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arterial ﬂow.10,29 As a routine, we only perform clinical
assessment in cases of impaired Doppler signal, and we
have never had a false negative in over 200 cases of the
use of the Cook–Swartz probe. We use continuous moni-
toring intraoperatively, during ﬂap insetting and closure,
and as shown in the case described, this has potentiated
revision in the setting of any changes in character or in-
tensity of the signal. In such cases, kinking, compression
or suturing of the pedicle may have occurred, and signal
changes can precipitate the removal of sutures and
inspection of the anastomosis. We continue continuous
monitoring in the immediate postoperative period, and
use intermittent audible signals as the basis for clinical
ﬂap monitoring for the ﬁrst postoperative week. There is
a short learning curve for medical and nursing staff, and
even patients can actively participate in their own ﬂap
monitoring. We have found patients ﬁnd reassurance in
the clear audible signal of the Doppler, and use the signal
in-between monitoring times. The strong trend towards
early ﬂap salvage (an improvement from 40% to 100%
salvage) was limited in statistical signiﬁcance by the
power of the study (only seven take-backs). With larger
numbers potentially proving the effect of improved ﬂap
salvage, further study is ongoing.
There are few disadvantages described in using an
implantable Doppler probe. The cuff itself has the poten-
tial to be applied incorrectly, as mentioned previously,
with a tight cuff potentially causing venous outﬂow
obstruction, while a loose cuff potentially causing false-
positive or false-negative results. Experience is the most
important factor in minimizing application problems, and
we have found the use of microclips to be highly useful
to achieve the appropriate tightness during application.
The major limitation of the use of the implantable Dopp-
ler probe is the increased ﬁnancial cost associated with
its use. The Cook–Swartz implantable Doppler system
itself costs US$3,000 (reusable) and the disposable probes
cost US$250 per patient. Of course, this needs to be eval-
uated in the context of the cost savings associated with
potentially salvaging 60% more ﬂaps.
The complete loss of the Doppler signal occurred in
two patients in the current series, and in both cases the
early detection of compromise enabled ﬂap salvage. In
both cases, the probe detected ﬂow abnormalities before
clinical signs were evident. As we leave the implantable
probe in situ for 4 weeks postoperatively, we have
encountered additional beneﬁts of the probe. During
dressing changes, both inpatient and outpatient, the probe
is used as a direct monitor for the degree of compression
to be used in dressings. In many cases, the signal has
become markedly altered or lost by overly tight dressings
and we have been able to adjust accordingly. Similarly,
during physiotherapy and rehabilitation, the probe is able
to guide the degree of knee and ankle movement, the
amount of weight bearing and the degree of mobilization.
With these techniques we have been able to mobilize
patients earlier than previously in a safe fashion due to
the ability of direct pedicle monitoring. In addition, the
implantable probe is useful for buried ﬂaps, where there
is no skin paddle available for monitoring.
CONCLUSION
The current study presents our experience with the
use of the Cook–Swartz implantable Doppler probe for
the monitoring of lower limb free ﬂaps, comparing this
group with an equivalent group of patients in whom rou-
tine clinical assessment was used. Although not statisti-
cally signiﬁcant, a trend toward early detection and sal-
vage of ﬂaps with anastomotic insufﬁciency was seen
with the use of the implantable Doppler probe. One ﬂap
loss in the clinically monitored group resulted in limb
amputation (the only amputation in the cohort), with no
amputations in the implantable Doppler probe group.
These ﬁndings suggest a beneﬁt of this technique as a
stand-alone or adjunctive tool for the clinical monitoring
of free ﬂaps, and suggests that further investigation is
warranted into the broader application of these devices.
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